SearchPublisher and Institutes
You are here: Home :: Area NEM :: Medical science :: Human medicine :: Nuclear medicine
M. nl, N.H. Temiz, A. engel
Myocardial indium-111-antimyosin uptake in essential hypertension
Keywords: Antimyosin, scintigraphy, hypertension, hypertrophy, echocardiography
AIM: Evaluation of myocardial uptake of 111In-anti-myosin antibodies in patients with essential hypertension for the verification of our hypothesis that it may increase in stage 1 in the left ventricle as a result of myocardial damage. PATIENTS, METHODS: Twelve men (mean age: 592.4 years) suffering from angina like symptoms and essential hypertension in clinical stage 1 according to the JNC-VI criteria were included into the study. These patients showed normal perfusion as revealed by thallium-201 myocardial study and coronary angiography. Left ventricular mass index was determined in echocardiography. Planar antimyosin images were obtained 48 h after the intravenous injection of the tracer. Heart to lung ratios were calculated as a parameter of myocardial tracer uptake using appropriate region of interests; values>1.52 were considered as abnormal. RESULTS: We observed increased anti-myosin uptake (mean: 1.710.12) consistent with myocardial damage in 11 of 12 patients. Nine of 12 patients had a left ventricular hypertrophy with left ventricular mass index values (mean: 131 g/m29.48) above 115 g/m2. Heart to lung ratio was correlated significantly to left ventricular mass index (r = 0.902, p<0.001) and duration of hypertension (r = 0.948, p<0.001). CONCLUSION: Our results suggest that 111In-antimyosin imaging may indicate myocyte damage in early phases of hypertensive heart disease.
Nuklearmedizin, Schattauer
Print ISSN: 0029-5566
Volume: 42, 01/2003
Pages: 99 - 103